Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial)
Authors:
- Maurizio VolterraniMVMaurizio Volterrani
- Giuseppe CaminitiGiuseppe Caminiti
- Giuseppe M.C. RosanoGRGiuseppe M.C. Rosano
- 1 September 2011
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 151 (2) , 218-224
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Ethics in the authorship and publishing of scientific articlesInternational Journal of Cardiology, 2010
- Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trialThe Lancet, 2010
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled studyThe Lancet, 2010
- Heart Rate Control in an Unselected Consecutive Population of Outpatients With Stable Coronary Artery Disease: Analysis of the CARDIf Study CohortAngiology, 2010
- Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trialEuropean Heart Journal, 2009
- Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trialEuropean Heart Journal, 2005
- A Validated Prediction Model for All Forms of Acute Coronary SyndromeJAMA, 2004
- β-Blockers in Chronic Heart FailureCirculation, 2003
- Effect of timolol on mortality and reinfarction after acute myocardial infarction: Prognostic importance of heart rate at restThe American Journal of Cardiology, 1986
- Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trialsThe American Journal of Cardiology, 1986